Kemanetzi C, Lallas K, Lazaridou E, et al. The Impact of Immune Checkpoint Inhibitors-Induced Skin Toxicity on Patients’ Quality of Life and the Role of Dermatologic Intervention. Dermatol Pract Concept. 2024;14(3):e2024118. doi:10.5826/dpc.1403a118